Journal article
Double-blind study of clozapine dose response in chronic schizophrenia
The American journal of psychiatry, v 156(11), pp 1744-1750
01 Nov 1999
PMID: 10553738
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Fifty patients who met Kane et al.'s criteria for treatment-refractory schizophrenia or schizoaffective disorder were studied. All subjects were randomly assigned to 100, 300, or 600 mg/day of clozapine for 16 weeks of double-blind treatment. Forty-eight patients completed this first 16 weeks. Of the 50 patients, 36 went on to second and third 16-week trials of double-blind treatment at the remaining doses.
Metrics
9 Record Views
Details
- Title
- Double-blind study of clozapine dose response in chronic schizophrenia
- Creators
- George Simpson - Drexel UniversityRichard JosiassenJoseph StanillaJose de Leon
- Publication Details
- The American journal of psychiatry, v 156(11), pp 1744-1750
- Publisher
- American Psychiatric Association
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Psychiatry
- Web of Science ID
- WOS:000083446100012
- Scopus ID
- 2-s2.0-0032730108
- Other Identifier
- 991019168014104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Psychiatry